Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy.
IMPORTANCE: Neuromyelitis optica (NMO) is an inflammatory disease of the optic nerves and spinal cord that leads to blindness and paralysis. Effective immunosuppression is the standard of care for relapse prevention. OBJECTIVE: To compare the relapse and treatment failure rates among patients receiv...
主要な著者: | Mealy, M, Wingerchuk, D, Palace, J, Greenberg, B, Levy, M |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2014
|
類似資料
-
Treatment of Neuromyelitis Optica: Review and Recommendations.
著者:: Kimbrough, D, 等
出版事項: (2012) -
Treatment of neuromyelitis optica: Review and recommendations
著者:: Kimbrough, D, 等
出版事項: (2012) -
Neuromyelitis optica relapses: race and rate, immunosuppression and impairment
著者:: Tackley, G, 等
出版事項: (2016) -
TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
著者:: Elsone, L, 等
出版事項: (2012) -
B-Cell Targeted Treatments for Neuromyelitis Optica Spectrum Disorder: A Focus on CD19 and CD20
著者:: Levy M, 等
出版事項: (2021-08-01)